medigraphic.com
ISSN 1561-3070 (Electronic)

2019, Number 3

<< Back

Rev Cub Oftal 2019; 32 (3)

Polymerase chain reaction in ocular fluids in atypical forms of posterior uveitis

Ambou FI, González DRE, Ginorio GD, Fraga NJ, Galano FE, Ramos BL

Language: Spanish
References: 11
Page: 1-8
PDF size: 406.86 Kb.


ABSTRACT

Ocular toxoplasmosis is the most frequent cause of posterior uveitis in many countries. Correct diagnosis is mainly based on the clinical characteristics of the disease, but in atypical forms of posterior uveitis laboratory support is required to confirm the diagnosis and not indicate inappropriate treatments. Evidence is provided of the usefulness of polymerase chain reaction in ocular fluids from patients with serum serological titers positive for toxoplasma and atypical presentations of posterior uveitis. A clinical case is presented of a female patient with systemic toxoplasmosis confirmed by positive serum serological titers and concomitant bilateral posterior uveitis without typical features of ocular toxoplasmosis, in which polymerase chain reaction in ocular fluids was essential for the diagnosis. Polymerase chain reaction in ocular fluids is an unequivocal tool for the correct diagnosis of atypical forms of posterior uveitis.


REFERENCES

  1. Ben-Harari1 RR, Goodwin E, Casoy J. Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: A systematic review. Drugs RD. 2017;17:523-44.

  2. Previato M, Frederico FB, Murata FHA, Siqueira RC, Barbosa AP. A Brazilian report using serological and molecular diagnosis to monitoring acute ocular toxoplasmosis. BMC Res Notes. 2015;7(8):746.

  3. Rubio Rodríguez CG, Rodríguez Gil R, Pérez Muñoz D, Kalitovics Nobregas N, Álvarez Reyes F. Toxoplasmosis ocular adquirida en este medio. Revisión de casos. Arch Soc Canar Oftalmol. 2016;27:55-62.

  4. Álvarez G, Rey A, Adan A. Clinical features of ocular toxoplasmosis in an inmigrant population in the Barcelona area: Study in 22 patients. Arch Soc Esp Oftalmol. 2010;85:202-8.

  5. Holland GN. Ocular toxoplasmosis: a global reassessment. Am J Ophthalmol. 2004;137:1-17.

  6. Garweg JG, de Groot-Mijnes JD, Montoya JG. Diagnostic approach to ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19:255-61.

  7. Bourdin C, Busse A, Kouamou E, Touafek F, Bodaghi B, Le Hoang P. PCR-based detection of Toxoplasma gondii DNA in blood and ocular samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol. 2014;52(11):3987-91.

  8. Regalado B, Rodríguez M, Fraga J, Rojas L, Núñez FA, Jerez LE. Aplicación de herramientas serológicas y moleculares para el diagnóstico de coriorretinitis por Toxoplasma gondii. Rev Cubana Med Trop. 2013;65:5.

  9. Prasad A, Van Gelder R. Presumed ocular histoplasmosis syndrome. Curr Opin Ophthalmol. 2005;16:364-8.

  10. Ehlers J, Hawkins B, Schachat A. Ocular histoplasmosis. En: Ryan A, Sadda A, Hilton D, Schachat A, Wilkinson C, Widemann P. Retina. 5 ed. EE.UU.: Elsevier;2013:1274-84.

  11. Thuruthumaly C, Chin-Yee D, Kumar-Rao P. Presumed ocular histoplasmosis. Curr Opin Ophthalmol. 2014;25:01-5.




2020     |     www.medigraphic.com